Explore
Validate
LearnHPA069711
antibody from Atlas Antibodies
Targeting: NFAT5
KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP
Immunocytochemistry
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA069711 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA069711, RRID:AB_2686180
- Product name
- Anti-NFAT5
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human NFAT5, Gene description: nuclear factor of activated T-cells 5, tonicity-responsive, Alternative Gene Names: KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP, Validated applications: ChIP, ICC, IHC, Uniprot ID: O94916, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
Topalov N, Mayr D, Scherer C, Chelariu-Raicu A, Beyer S, Hester A, Kraus F, Zheng M, Kaltofen T, Kolben T, Burges A, Mahner S, Trillsch F, Jeschke U, Czogalla B
Frontiers in Oncology 2021;11
Frontiers in Oncology 2021;11
Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
Qin X, Li C, Guo T, Chen J, Wang H, Wang Y, Xiao Y, Li J, Liu P, Liu Z, Liu Q
Journal of Experimental & Clinical Cancer Research 2017;36(1)
Journal of Experimental & Clinical Cancer Research 2017;36(1)
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- ChIP-Exo-Seq composite graph for Anti-NFAT5 (HPA069711, Lot 000020184) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.
